Literature DB >> 11169799

MRI study of immediate cell viability in focused ultrasound lesions in the rabbit brain.

L Chen1, D M Bouley, B T Harris, K Butts.   

Abstract

The purpose of this study was to evaluate cell viability in MR imaged focused ultrasound (FUS) lesions using cell-viability staining with triphenyl tetrazolium chloride (TTC) and both light and electron microscopy. Ten paired ultrasonic lesions were created in 5 rabbit brains in vivo with an ultrasound beam of 1.5 MHz electrical power input to the transducer of 50 W and exposure duration of 15 seconds. T2-weighted fast spin-echo (FSE) MRI was performed to detect the FUS lesions in the brain 4 hours after treatment, after which the animals were immediately euthanized. Lesion sizes were measured on TTC-stained specimens, histological sections stained with hematoxylin and eosin (H&E), and T2-weighted MR images. The differences between the lesion diameters measured with the three methods were within the range of 0.1--0.7 mm. The lesion sizes measured from MRI correlated well with those seen from H&E sections. The measurements from MRI slightly overestimated lesion sizes on TTC-stained wet tissues by approximately one MRI pixel (0.31 mm). Electron microscopy demonstrated nuclear and cytoplasmic ultrastructural damage within the grey-white, non-TTC-stained lesion zone, whereas the TTC-stained normal tissue showed preservation of neuronal ultrastructure. Therefore, MR-imaged lesions represent a cell-death zone in rabbit brain 4 hours after FUS ablation, with slight overestimation by approximately one MRI pixel. J. Magn. Reson. Imaging 2001;13:23-30. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169799     DOI: 10.1002/1522-2586(200101)13:1<23::aid-jmri1004>3.0.co;2-g

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

Review 1.  Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications.

Authors:  Pejman Ghanouni; Kim Butts Pauly; W Jeff Elias; Jaimie Henderson; Jason Sheehan; Stephen Monteith; Max Wintermark
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

2.  Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy: in vivo evaluation under MR guidance.

Authors:  Adam M Kinsey; Chris J Diederich; Viola Rieke; William H Nau; Kim Butts Pauly; Donna Bouley; Graham Sommer
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

3.  Ultrasound interstitial thermal therapy (USITT) for the treatment of uterine myomas.

Authors:  William H Nau; Chris J Diederich; Jeff Simko; Titania Juang; Alison Jacoby; E Clif Burdette
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-02-09

4.  Imaging findings in MR imaging-guided focused ultrasound treatment for patients with essential tremor.

Authors:  M Wintermark; J Druzgal; D S Huss; M A Khaled; S Monteith; P Raghavan; T Huerta; L C Schweickert; B Burkholder; J J Loomba; E Zadicario; Y Qiao; B Shah; J Snell; M Eames; R Frysinger; N Kassell; W J Elias
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-26       Impact factor: 3.825

5.  Mapping Cell Viability Quantitatively and Independently From Cell Density in 3D Gels Noninvasively.

Authors:  Brian J Archer; Julia J Mack; Sara Acosta; Russell Nakasone; Fadi Dahoud; Khalid Youssef; Abraham Goldstein; Amichai Goldsman; Mathias C Held; Martin Wiese; Bernhard Blumich; Matthias Wessling; Meike Emondts; Jurgen Klankermayer; M Luisa Iruela-Arispe; Louis-S Bouchard
Journal:  IEEE Trans Biomed Eng       Date:  2021-09-20       Impact factor: 4.756

6.  A preclinical study of diffusion-weighted MRI contrast as an early indicator of thermal ablation.

Authors:  Steven P Allen; Francesco Prada; Zhiyuan Xu; Jeremy Gatesman; Xue Feng; Helen Sporkin; Yekaterina Gilbo; Sydney DeCleene; Kim Butts Pauly; Craig H Meyer
Journal:  Magn Reson Med       Date:  2020-11-11       Impact factor: 3.737

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.